Moreover, the dependency of TFIIH-CAK on the melanocyte master regulator MITF or its structural homolog c-MYC extends the conceptional idea of a CDK7-targeted treatment approach to melanoma far beyond super-enhancers as determinants of oncogenesis. The gene discussed is MYC; the disease is melanoma.